Flood of Warning Letters Follows DTC ad Clampdown

FDA issues warning letters to drug companies alleging misleading advertisements

The FDA on Tuesday released approximately 100 warning letters it had sent to drug companies on September 9, alleging that the companies made false or misleading claims on their websites or in electron...

Jarvis: Trump’s crackdown on drug ads is long overdue

The Trump administration’s crackdown on pharmaceutical ads is a welcome step toward lessening Big Pharma’s influence over conversations between patients and their doctors. Americans are among the few people in the world bombarded with advertisements for medications most of us don’t need — New Zealand is the only other country that allows direct-to-consumer drug advertising. These policies have given pharmaceutical companies significant influence…

Flood of warning letters follows DTC ad clampdown

The FDA has lost no time following through on its plan to tighten up DTC advertising of medicines, sending out dozens of untitled and warning letters.

FDA warning letters show how it intends to ratchet up pressure over drug ads

The FDA's crackdown is unprecedented, but some experts questioned whether the agency has the staff to carry it out

Check out 15 DTC pharma ads that got flagged by FDA

Drugmakers are officially on notice about their direct-to-consumer ads. Over the past week, the Food and Drug Administration has issued an estimated 100 warning letters to pharma and biotech companies over claims their DTC ads are violative in nature. This action comes amid a concerted step up in…

FDA’s Crackdown on Rx Drug Promotion Ramps Up with Release of Letters

In a follow-up to FDA’s September 9 announcement that it would crackdown on deceptive direct-to-consumer (DTC) advertising, including issuing approximately 100 cease-and-desist letters, FDA has now…